| Literature DB >> 29891004 |
Francois Kiemde1,2,3, Marc Christian Tahita4, Palpouguini Lompo4, Toussaint Rouamba4, Athanase M Some4, Halidou Tinto4, Petra F Mens5, Henk D F H Schallig5, Michael Boele van Hensbroek6.
Abstract
BACKGROUND: Fever remains a major public health problem. In Burkina Faso, more than half of febrile children are considered not to be infected by malaria. This study prospectively assessed probable (treatable) causes of fever in Burkinabe children.Entities:
Keywords: Children; Fever; Infectious diseases; Malaria
Mesh:
Year: 2018 PMID: 29891004 PMCID: PMC5994647 DOI: 10.1186/s40249-018-0442-3
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Fig. 1Study flow chart
Demographic characteristics, clinical symptoms and basic laboratory findings of study subjects enrolled in the present study in four rural health centres and one referral hospital in Nanoro Health district
| Category | Subcategory |
| Proportion (%) |
|---|---|---|---|
| Gender | Male | 369 | 53.95 |
| Female | 315 | 46.05 | |
| Age | ≤12 months | 201 | 29.39 |
| >12 months | 483 | 70.61 | |
| Temperature | ≥37.5 °C–≤38.5 °C | 340 | 49.71 |
| >38.5 °C–≤39.5 °C | 242 | 35.38 | |
| >39.5 °C | 102 | 14.91 | |
| Duration of fever | 1 day | 108 | 15.79 |
| 2–3 days | 518 | 75.73 | |
| 4–7 days | 56 | 8.19 | |
| >7 days | 2 | 0.29 | |
| Vaccination according to the EPI | Yes | 449 | 65.64 |
| No | 133 | 19.44 | |
| Unknown | 102 | 14.91 | |
| Common symptoms | Cough | 335 | 48.98 |
| Diarrhoea | 266 | 38.89 | |
| Vomiting | 123 | 17.98 | |
| Others | 55 | 8.04 | |
| Basic laboratory findings | Haemoglobin rate | ||
| < 8 g/dl | 180 | 26.32 | |
| ≥ 8 g/dl–<11 g/dl | 418 | 61.11 | |
| ≥11 g/dl | 86 | 12.57 | |
| White blood cells | |||
| <4 × 103 cells/mm3 | 10 | 1.46 | |
| ≥4 ×103 cells/mm3–< 12 × 103 cells/mm3 | 348 | 50.88 | |
| ≥12 × 103 cells/mm3 | 326 | 47.66 |
EPI Expanded program of immunization
Microbiology and malaria microscopy findings of children under-5 years enrolled in the study
| Subcategory | General population | Referral hospital | Health facilities |
|---|---|---|---|
| Malaria microscopy | 684/684 (100) | 138/138 (100) | 546/546 (100) |
| Malaria microscopy positive | 340/684 (49.71) | 41/138 (29.71) | 299/546 (54.76) |
| | 340/340 (100) | 41/138 (29.71) | 299/546 (54.76) |
| | 04/340 (0.88) | 0/138 (0) | 4/299 (1.34) |
| | 01/340 (0.29) | 0/138 (0) | 1/299 (0.33) |
| Blood cultures ( | 684/684 (100) | 138/138 (100) | 546/546 (100) |
| Bacterial culture positive | 41/684 (5.99) | 21/138 (15.22) | 20/546 (3.66) |
| | 31/41 (75.61) | 19/21 (90.48) | 12/20 (60.00) |
| | 02/41 (4.88) | 00 | 02/20 (10.00) |
| | 01/41 (2.44) | 00 | 01/20 (5.00) |
| | 02/41 (4.88) | 01/21 (4.76) | 01/20 (5.00) |
| | 03/41 (7.31) | 01/21 (4.76) | 02/20 (10.00) |
| | 02/41 (4.88) | 00 | 02/20 (10.00) |
| Urine examination ( | 507/684 (74.12) | 94/138 (68.12) | 413/546 (75.64) |
| Bacterial culture positive | 10/507 (1.97) | 04/94 (4.26) | 06/413 (1.45) |
| | 10/10 (100.00) | 04/4 (100) | 06/6 (100) |
| Stool examinations ( | 523/684 (76.46) | 85/138 (61.60) | 438/546 (80.22) |
| Bacterial culture positive | 40/523 (7.65) | 09/85 (10.59) | 31/438 (7.08) |
| | 20/40 (50.00) | 08/9 (88.89) | 16/31 (38.71) |
| | 17/40 (42.50) | 01/9 (11.11) | 16/31 ()51.61 |
| | 03/40 (7.50) | 00 | 03/31 (9.69) |
| Parasites positive | 143/523 (27.34) | 17/85 (20.00) | 126/438 (28.77) |
| Mono parasitosisb | 115/143 (80.42) | 11/17 (64.71) | 104/126 (82.54) |
| Bi parasitosis | 25/143 (17.48) | 05/17 (29.41) | 20/126 (15.87) |
| Tri parasitosis | 03/143 (2.10) | 01/17 (5.88) | 02/126 (1.59) |
| Rotavirus/Adenovirus positive | 25/523 (4.78) | 04/85 (4.71) | 21/438 (4.80) |
| Rotavirus | 15/25 (60.00) | 00 | 15/21 (71.43) |
| Adenovirus | 10/25 (40.00) | 04/4 (100) | 06/21 (28.57) |
| Nasopharyngeal cultures ( | 629/684 (91.95) | 137/138 (99.28) | 492/546 (90.11) |
| Bacterial culture positive | 153/629 (24.32) | 41/137 (29.71) | 112/492 (22.77) |
| | 148/153 (96.73) | 41/41 (100) | 107/112 (95.54) |
| | 05/153 (3.27) | 00 | 05/112 (4.46) |
| No pathogens detected | 162/684 (23.68) | 40/138 (28.99) | 122/546 (22.34) |
a: 5 children infection with Plasmodium falciparum were co-infected with P. malariae and P. ovale
b: Giardia intestinalis: 35.65%; Trichomonas intestinalis: 22.61%; Endolimax nana: 17.40%; Entamoeba coli: 13.91%; Entamoeba hystolitica: 7.82%; Others: 2.61%
Fig. 2Distribution of pathogens found with microbiology during the whole study (year 2015). BSI Bloodstream infection (bacterial), GII Gastro-intestinal infection (all), UTI Urinary tract infection, CBPN common bacterial pathogens of nasopharynx
Interaction between malaria and others pathogens studied
| Malaria microscopy positive (340) | Malaria microscopy negative (344) | |
|---|---|---|
| Other infections | 154 (45.29) | 182 (52.91) |
| Probable cause of fever (BSI, vGII, UTI) | 11 (3.23) | 62 (18.02) |
| No probable causes of fever (pGII, bGII, CBPN) | 143 (42.05) | 136 (39.53) |
| bBSI | 6 (1.76) | 35 (10.17) |
| GII (all) | 90 (26.47) | 103 (29.94) |
| pGII | 77 (22.64) | 66 (19.18) |
| bGII | 17 (5.0) | 23 (6.69) |
| vGII | 3 (0.88) | 22 (6.40) |
| CBPN | 75 (22.05) | 78 (22.67) |
| UTI | 3 (0.88) | 7 (2.03) |
bBSI bacterial bloodstream infection, GII Gastro-intestinal infection, pGII parasitic gastro-intestinal infection, bGII bacterial gastro-intestinal infection, vGII viral gastro-intestinal infection, UTI Urinary tract infection, CBPN Common bacterial pathogens of nasopharynx
Correlation between malaria, BSI, UTI, GII and CBPN and demographic, clinical and laboratory data
| Malaria | Blood stream infection | Urinary tract infection | Gastro-intestinal infection | CBPN | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||||
| Male | 1 | 1 | 1 | 1 | 1 | |||||
| Female | 1.19 (0.88–1.61) | 0.255 | 1.01 (0.53–1.91) | 0.969 | 1.22 (0.34–4.45) | 0.752 | 1.18 (0.83–1.69) | 0.350 | 1.18 (0.82–1.70) | 0.381 |
| Age | ||||||||||
| ≤12 months | 1 | 1 | 1 | 1 | 1 | |||||
| >12 months | 2.85 (2.02–4.06) | <0.001* | 0.70 (0.37–1.39) | 0.299 | 0.34 (0.09–1.25) | 0.094 | 2.88 (1.86–4.58) | <0.001* | 0.90 (0.61–1.35) | 0.609 |
| Temperature | ||||||||||
| 37.5 °C–38.5 °C | 1 | 1 | 1 | 1 | 1 | |||||
| 38.5 °C–39.5 °C | 1.26 (0.91–1.76) | 0.166 | 1.28 (0.64–2.51) | 0.479 | 1.93 (0.50–7.92) | 0.330 | 0.99 (0.67–1.47) | 0.963 | 1.21 (0.81–1.80) | 0.334 |
| >39.5 °C | 2.06 (1.31–3.26) | 0.002* | 0.87 (0.28–2.23) | 0.789 | 0.86 (0.04–5.90) | 0.891 | 1.13 (0.67–1.89) | 0.647 | 0.90 (0.50–1.55) | 0.714 |
| White cell counts | ||||||||||
| 4 × 103–12 × 103 | 1 | 1 | 1 | 1 | 1 | |||||
| <4 × 103 cells/mm3 | 1.18 (0.33–4.67) | 0.803 | 0.35 (0.02–7.31) | 0.828 | 0.66 (0.20–26.68) | 0.828 | 1.55 (0.36–6.70) | 0.540 | 1.13 (0.01–2.31) | 0.166 |
| ≥12 × 103 mm3 | 0.58 (0.43–0.79) | <0.001* | 1.03 (0.55–1.91) | 0.206 | 2.25 (0.64–7.92) | 0.206 | 0.79 (0.55–1.14) | 0.211 | 1.36 (0.94–1.95) | 0.100 |
| Anaemia | ||||||||||
| ≥11 g/dl | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| <8 g/dl | 4.06 (2.35–7.20) | <0.001* | 1.60 (0.54–5.80) | 0.426 | 1.50 (0.31–10.70) | 0.631 | 1.71 (0.39–1.28) | 0.252 | 1.16 (0.64–1.18) | 0.625 |
| 8 g/dl–11 g/dl | 2.51 (1.53–4.24) | <0.001* | 1.25 (0.47–4.33) | 0.688 | 0.34 (0.06–2.65) | 0.248 | 0.60 (0.35–1.01) | 0.052 | 0.81 (0.46–1.44) | 0.453 |
| Vaccination according EPI | ||||||||||
| Yes | 1 | 1 | 1 | 1 | 1 | |||||
| No | 0.78 (0.52–1.14) | 0.204 | 0.68 (0.25–1.58) | 0.409 | 0.12 (0.01–2.05) | 0.145 | 1.23 (0.81–1.98) | 0.294 | 0.98 (0.60–1.58) | 0.950 |
| Unknown | 1.32 (0.86–2.05) | 0.204 | 0.90 (0.33–2.10) | 0.829 | 0.16 (0.01–2.66) | 0.201 | 1.11 (0.64–1.88) | 0.709 | 1.06 (0.63–1.73) | 0.829 |
*P-value is statistically significant
BSI Blood stream infection, UTI Urinary tract infection, GII Gastro - intestinal infection, CBPN Common bacterial pathogens of nasopharynx